Paris, France

Clara Nahmias

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Clara Nahmias: Innovator in Nucleic Acid Research

Introduction

Clara Nahmias is a prominent inventor based in Paris, France. She has made significant contributions to the field of molecular biology, particularly in the study of nucleic sequences and their interactions with receptors. Her work has led to the development of innovative applications in genetic research.

Latest Patents

Clara Nahmias holds 2 patents. Her latest patents include "Nucleic sequences coding for an AT2 interacting proteins interacting with the AT2 receptor and their applications." This invention concerns nucleic sequences coding for a protein capable of interacting with the AT2 receptor, oligonucleotides included in said sequences, their applications as probes, and for expressing said proteins. It also involves vectors useful for said expression, host cells containing said vectors, and a study model of the AT2 receptor. Additionally, the invention concerns said proteins and their uses, with isolated nucleic acid fragments coding for a protein capable of binding with the AT2 receptor selected from the group consisting of the sequences SEQ ID NO: 1, 3, 5, 7, and 9.

Career Highlights

Throughout her career, Clara has worked with esteemed institutions, including the Centre National de la Recherche Scientifique. Her research has been pivotal in advancing our understanding of receptor interactions and their implications in various biological processes.

Collaborations

Clara has collaborated with notable colleagues such as Arthur Donny Strosberg and Laurent Jean Emorine. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Clara Nahmias is a trailblazer in the field of nucleic acid research, with a focus on receptor interactions. Her patents and collaborations reflect her commitment to advancing scientific knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…